STOCK TITAN

Actinium grants director 61.6K RSUs, 92.4K options

Director Ajit Shetty received new RSU and stock option awards from Actinium Pharmaceuticals, adding to his direct equity stake.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Actinium Pharmaceuticals, Inc. (symbol: ATNM) is the issuer of record for a Form 4 filing submitted to the SEC. Shetty Ajit reported acquisition or exercise transactions in this Form 4 filing.

Actinium Pharmaceuticals, Inc. (ATNM) reported that director Ajit Shetty received equity awards on September 2, 2026. He was granted 61,600 shares of Common Stock as restricted stock units, which vest in three equal annual installments, and 92,400 stock options exercisable at $1.00 per share that vest in fifty equal monthly tranches. Following these awards, he holds 62,357 shares of Common Stock directly and 92,400 stock options. No Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider Shetty Ajit
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F2 92,400 $0.00 $0.00
Grant/Award Common Stock F1 61,600 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 92,400 contracts (Direct); Common Stock — 62,357 shares (Direct)
Footnotes (2)
  1. F1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant.
  2. F2. The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant.
RSUs granted 61,600 shares Restricted stock units of Common Stock granted to Ajit Shetty on September 2, 2026
Stock options granted 92,400 options Stock options granted to Ajit Shetty on September 2, 2026
Option exercise price $1.00 per share Exercise price for the 92,400 stock options granted on September 2, 2026
Common shares held after transaction 62,357 shares Direct Common Stock holdings of Ajit Shetty following the September 2, 2026 awards
Option expiration date September 2, 2036 Expiration date of the 92,400 stock options
RSU vesting schedule 3 equal annual installments 1/3 per year on the first, second, and third anniversaries of the grant date
Option vesting tranches 50 monthly tranches Stock options vest in fifty equal monthly installments starting on the grant date
restricted stock units financial
"Represents a grant of restricted stock units ("RSUs"). The RSUs vest"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vesting financial
"The RSUs vest as follows: 1/3 on the first anniversary of the date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
stock options financial
"The stock options vest and become exercisable in fifty equal monthly"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"conversion_or_exercise_price": "1.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

What equity awards did director Ajit Shetty receive from ATNM on September 2, 2026?

Ajit Shetty received 61,600 restricted stock units of Common Stock and 92,400 stock options with an exercise price of $1.00 per share, both granted on September 2, 2026 as reported by Actinium Pharmaceuticals (ATNM).

How do the new RSUs granted to Ajit Shetty by ATNM vest?

The 61,600 RSUs granted to Ajit Shetty vest in three equal installments: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary, and 1/3 on the third anniversary of the September 2, 2026 grant.

What is the vesting schedule of Ajit Shetty’s new ATNM stock options?

The 92,400 stock options granted to Ajit Shetty vest and become exercisable in fifty equal monthly tranches, beginning on the September 2, 2026 grant date, and carry an exercise price of $1.00 per share with expiration on September 2, 2036.

How many ATNM shares does Ajit Shetty own directly after these transactions?

After the reported awards, Ajit Shetty directly holds 62,357 shares of Common Stock of Actinium Pharmaceuticals, Inc. (ATNM), in addition to 92,400 stock options granted on September 2, 2026.

Were Ajit Shetty’s ATNM transactions made under a Rule 10b5-1 trading plan?

No. The filing indicates the Rule 10b5-1 checkbox is not affirmed, and no footnote states that the September 2, 2026 equity awards to Ajit Shetty were made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shetty Ajit

(Last)(First)(Middle)
C/O ACTINIUM PHARMACEUTICALS, INC.
100 PARK AVE., 23RD FLOOR

(Street)
NEW YORK NEW YORK 10017

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Actinium Pharmaceuticals, Inc. [ ATNM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/02/2026A61,600(1)A$062,357D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$109/02/2026A92,400 (2)09/02/2036Common Stock92,400$092,400D
Explanation of Responses:
1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant.
2. The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant.
/s/ Ajit Shetty09/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)